Literature DB >> 19131232

Pompe disease: a neuromuscular disease with respiratory muscle involvement.

Uwe Mellies1, Frédéric Lofaso.   

Abstract

Pompe disease is a single disease continuum that includes variable neuromuscular symptoms and rates of progression. However, specific clinical features, such as an early onset of respiratory problems preceding limb muscular weakness, distinguish Pompe disease from other neuromuscular diseases in which respiratory insufficiency occurs after loss of ambulation. The management of Pompe disease also differs from other neuromuscular diseases in that specific treatment is now available, making early recognition of the disease a priority. The results from clinical trials with recombinant human acid alpha-glucosidase have been published, and they show promising results with regards to the improvement of respiratory function in patients with Pompe disease. This review aims to give an overview of Pompe disease and to describe the current concepts of the disease. A focus is placed on the pathophysiology and clinical presentation of respiratory muscle involvement in adults. Additionally, new approaches and therapies available for the management of respiratory complications observed in Pompe disease are discussed in detail.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131232     DOI: 10.1016/j.rmed.2008.12.009

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  33 in total

1.  Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines.

Authors:  Mai K ElMallah; Silvia Pagliardini; Sara M Turner; Anthony J Cerreta; Darin J Falk; Barry J Byrne; John J Greer; David D Fuller
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

2.  Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Authors:  Stephan Wenninger; Eva Greckl; Haris Babačić; Kristina Stahl; Benedikt Schoser
Journal:  J Neurol       Date:  2018-11-14       Impact factor: 4.849

3.  Inspiratory Muscle Training in Late-Onset Pompe Disease: The Effects on Pulmonary Function Tests, Quality of Life, and Sleep Quality.

Authors:  Goksen Kuran Aslan; Burcu Ersoz Huseyinsinoglu; Piraye Oflazer; Nilgun Gurses; Esen Kiyan
Journal:  Lung       Date:  2016-04-22       Impact factor: 2.584

Review 4.  Metabolic myopathies: functional evaluation by different exercise testing approaches.

Authors:  L Volpi; G Ricci; D Orsucci; R Alessi; F Bertolucci; S Piazza; C Simoncini; M Mancuso; G Siciliano
Journal:  Musculoskelet Surg       Date:  2011-03-04

Review 5.  The respiratory neuromuscular system in Pompe disease.

Authors:  David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2013-06-21       Impact factor: 1.931

Review 6.  Long-term outcome and unmet needs in infantile-onset Pompe disease.

Authors:  Andreas Hahn; Anne Schänzer
Journal:  Ann Transl Med       Date:  2019-07

7.  Systemic Delivery of AAVB1-GAA Clears Glycogen and Prolongs Survival in a Mouse Model of Pompe Disease.

Authors:  Allison M Keeler; Marina Zieger; Sophia H Todeasa; Angela L McCall; Jennifer C Gifford; Samantha Birsak; Sourav R Choudhury; Barry J Byrne; Miguel Sena-Esteves; Mai K ElMallah
Journal:  Hum Gene Ther       Date:  2018-07-25       Impact factor: 5.695

8.  Peripheral nerve and neuromuscular junction pathology in Pompe disease.

Authors:  Darin J Falk; Adrian Gary Todd; Sooyeon Lee; Meghan S Soustek; Mai K ElMallah; David D Fuller; Lucia Notterpek; Barry J Byrne
Journal:  Hum Mol Genet       Date:  2014-09-12       Impact factor: 6.150

Review 9.  Common mechanisms of compensatory respiratory plasticity in spinal neurological disorders.

Authors:  Rebecca A Johnson; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2013-05-28       Impact factor: 1.931

10.  Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD).

Authors:  Federica Montagnese; Francesca Granata; Olimpia Musumeci; Carmelo Rodolico; Stefania Mondello; Emanuele Barca; Maria Cucinotta; Anna Ciranni; Marcello Longo; Antonio Toscano
Journal:  J Inherit Metab Dis       Date:  2016-02-01       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.